Loading…

Bagels and LOX in patients with eosinophilic esophagitis

[...]after impaired barrier function mediated by a number of pathways, including lost expression of the homeostatic antiprotease serine protease inhibitor, Kazal type 7,4 the epithelium releases the pro-TH2 cytokine thymic stromal lymphopoietin, which is encoded for by the chief EoE susceptibility l...

Full description

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology 2019-07, Vol.144 (1), p.41-43
Main Authors: Ben Baruch-Morgenstern, Netali, Shoda, Tetsuo, Rothenberg, Marc E.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c428t-9ee4918231e69326bd5409a4776723043d2f5cf63a6faf91e1f593f7c43f20e3
cites cdi_FETCH-LOGICAL-c428t-9ee4918231e69326bd5409a4776723043d2f5cf63a6faf91e1f593f7c43f20e3
container_end_page 43
container_issue 1
container_start_page 41
container_title Journal of allergy and clinical immunology
container_volume 144
creator Ben Baruch-Morgenstern, Netali
Shoda, Tetsuo
Rothenberg, Marc E.
description [...]after impaired barrier function mediated by a number of pathways, including lost expression of the homeostatic antiprotease serine protease inhibitor, Kazal type 7,4 the epithelium releases the pro-TH2 cytokine thymic stromal lymphopoietin, which is encoded for by the chief EoE susceptibility locus on 5q22, as well as other proinflammatory cytokines, including the alarmin IL-33.1 This initiates the TH2 inflammatory cascade by promoting secretion of TH2 cell–derived inflammatory cytokines, including IL-5 and IL-13.1 IL-13 stimulates the esophageal epithelium to secrete chemokines, such as CCL26 (eotaxin-3), and disrupts the epithelial barrier by downregulating expression of the adhesion molecule desmoglein 1 and simultaneously upregulating the protease calpain 14, which is the gene product encoded for by another chief EoE susceptibility loci (2p23).1,5 These processes promote accumulation of immune cells, predominantly eosinophils, mast cells, and basophils, that secrete TGF-β, a main cytokine in the fibrotic network.1 TGF-β is also generated by regulatory T cells that are overrepresented in the esophagi of patients with EoE.1 TGF-β acts on fibroblasts and stimulates their transdifferentiation into activated myofibroblasts that proliferate, migrate, and secrete collagen and other matrix component. Focusing on the association between gene expression and phenotype, one study showed that esophageal narrowing was associated with increased expression of CCL26, ALOX15, GRK5, CPA3, and TRIM2 in adults with EoE,6 whereas another study showed that pediatric patients with EoE with food impaction had distinct expression of regulators of esophageal motility, mast cell markers, and TH2-associated transcripts.7 Regarding endotypes, 3 clusters associate with distinct endotypes (ie, EoE endotypes 1-3) despite similar eosinophil levels.4 Interestingly, EoE endotype 3 was associated with the narrow-caliber esophagus and enriched for epithelial genes that lose expression, particularly ACPP, CITED2, CTNNAL1, EML1, FLG, GRPEL2, MT1M, PNLIPPR3, and TSPAN12. [...]up to 50% of patients might not even undergo evaluation because biopsy specimens are not deep enough to contain sufficient amount of lamina propria. [...]there is a need for better biomarkers for the fibrostenotic component of this disease.
doi_str_mv 10.1016/j.jaci.2019.03.034
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2229236817</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091674919305494</els_id><sourcerecordid>2229236817</sourcerecordid><originalsourceid>FETCH-LOGICAL-c428t-9ee4918231e69326bd5409a4776723043d2f5cf63a6faf91e1f593f7c43f20e3</originalsourceid><addsrcrecordid>eNp9kE1Lw0AQhhdRbK3-AQ8S8OIldb-yyYIXLX5BoZcevC3bzWy7IU3ibqL4793S6sGDMDAz8MzL8CB0SfCUYCJuq2mljZtSTOQUs1j8CI0JlnkqCpodozHGkqQi53KEzkKocNxZIU_RiBGcEVLwMSoe9BrqkOimTOaLt8Q1Sad7B00fkk_XbxJog2vabuNqZxIIcdJr17twjk6srgNcHPoELZ8el7OXdL54fp3dz1PDadGnEoBLUlBGQEhGxarMOJaa57nIKcOcldRmxgqmhdVWEiA2k8zmhjNLMbAJutnHdr59HyD0auuCgbrWDbRDUJRSSZkoSB7R6z9o1Q6-ic9FKsOZ4AVhkaJ7yvg2BA9Wdd5ttf9SBKudVlWpnVa106owi8Xj0dUhelhtofw9-fEYgbs9EF3ChwOvgokSDZTOg-lV2br_8r8B8JmGKQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2250564813</pqid></control><display><type>article</type><title>Bagels and LOX in patients with eosinophilic esophagitis</title><source>Elsevier</source><creator>Ben Baruch-Morgenstern, Netali ; Shoda, Tetsuo ; Rothenberg, Marc E.</creator><creatorcontrib>Ben Baruch-Morgenstern, Netali ; Shoda, Tetsuo ; Rothenberg, Marc E.</creatorcontrib><description>[...]after impaired barrier function mediated by a number of pathways, including lost expression of the homeostatic antiprotease serine protease inhibitor, Kazal type 7,4 the epithelium releases the pro-TH2 cytokine thymic stromal lymphopoietin, which is encoded for by the chief EoE susceptibility locus on 5q22, as well as other proinflammatory cytokines, including the alarmin IL-33.1 This initiates the TH2 inflammatory cascade by promoting secretion of TH2 cell–derived inflammatory cytokines, including IL-5 and IL-13.1 IL-13 stimulates the esophageal epithelium to secrete chemokines, such as CCL26 (eotaxin-3), and disrupts the epithelial barrier by downregulating expression of the adhesion molecule desmoglein 1 and simultaneously upregulating the protease calpain 14, which is the gene product encoded for by another chief EoE susceptibility loci (2p23).1,5 These processes promote accumulation of immune cells, predominantly eosinophils, mast cells, and basophils, that secrete TGF-β, a main cytokine in the fibrotic network.1 TGF-β is also generated by regulatory T cells that are overrepresented in the esophagi of patients with EoE.1 TGF-β acts on fibroblasts and stimulates their transdifferentiation into activated myofibroblasts that proliferate, migrate, and secrete collagen and other matrix component. Focusing on the association between gene expression and phenotype, one study showed that esophageal narrowing was associated with increased expression of CCL26, ALOX15, GRK5, CPA3, and TRIM2 in adults with EoE,6 whereas another study showed that pediatric patients with EoE with food impaction had distinct expression of regulators of esophageal motility, mast cell markers, and TH2-associated transcripts.7 Regarding endotypes, 3 clusters associate with distinct endotypes (ie, EoE endotypes 1-3) despite similar eosinophil levels.4 Interestingly, EoE endotype 3 was associated with the narrow-caliber esophagus and enriched for epithelial genes that lose expression, particularly ACPP, CITED2, CTNNAL1, EML1, FLG, GRPEL2, MT1M, PNLIPPR3, and TSPAN12. [...]up to 50% of patients might not even undergo evaluation because biopsy specimens are not deep enough to contain sufficient amount of lamina propria. [...]there is a need for better biomarkers for the fibrostenotic component of this disease.</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/j.jaci.2019.03.034</identifier><identifier>PMID: 31051184</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Autoimmune diseases ; Biomarkers ; Biopsy ; Calpain ; Chemokines ; Chromosome 2 ; Collagen ; Cytokines ; Desmoglein 1 ; Endoscopy ; Eosinophilic Esophagitis ; Eotaxin ; epithelial cells ; Epithelium ; Esophageal diseases ; Esophagitis ; Esophagus ; Fibroblasts ; fibrosis ; Gene expression ; Genotype &amp; phenotype ; Helper cells ; Humans ; Immunoregulation ; Inflammation ; Interleukin 13 ; Interleukin 5 ; Lamina propria ; Leukocytes (basophilic) ; Leukocytes (eosinophilic) ; Liquid oxygen ; Lymphocytes ; Lymphocytes T ; Lysyl oxidase ; Phenotypes ; Protease ; Protein-Lysine 6-Oxidase ; Proteinase inhibitors ; Smooth muscle ; Susceptibility ; TGF-β ; Thymus ; TNF-α ; Tumor Necrosis Factor-alpha</subject><ispartof>Journal of allergy and clinical immunology, 2019-07, Vol.144 (1), p.41-43</ispartof><rights>2019</rights><rights>Copyright Elsevier Limited Jul 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c428t-9ee4918231e69326bd5409a4776723043d2f5cf63a6faf91e1f593f7c43f20e3</citedby><cites>FETCH-LOGICAL-c428t-9ee4918231e69326bd5409a4776723043d2f5cf63a6faf91e1f593f7c43f20e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31051184$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ben Baruch-Morgenstern, Netali</creatorcontrib><creatorcontrib>Shoda, Tetsuo</creatorcontrib><creatorcontrib>Rothenberg, Marc E.</creatorcontrib><title>Bagels and LOX in patients with eosinophilic esophagitis</title><title>Journal of allergy and clinical immunology</title><addtitle>J Allergy Clin Immunol</addtitle><description>[...]after impaired barrier function mediated by a number of pathways, including lost expression of the homeostatic antiprotease serine protease inhibitor, Kazal type 7,4 the epithelium releases the pro-TH2 cytokine thymic stromal lymphopoietin, which is encoded for by the chief EoE susceptibility locus on 5q22, as well as other proinflammatory cytokines, including the alarmin IL-33.1 This initiates the TH2 inflammatory cascade by promoting secretion of TH2 cell–derived inflammatory cytokines, including IL-5 and IL-13.1 IL-13 stimulates the esophageal epithelium to secrete chemokines, such as CCL26 (eotaxin-3), and disrupts the epithelial barrier by downregulating expression of the adhesion molecule desmoglein 1 and simultaneously upregulating the protease calpain 14, which is the gene product encoded for by another chief EoE susceptibility loci (2p23).1,5 These processes promote accumulation of immune cells, predominantly eosinophils, mast cells, and basophils, that secrete TGF-β, a main cytokine in the fibrotic network.1 TGF-β is also generated by regulatory T cells that are overrepresented in the esophagi of patients with EoE.1 TGF-β acts on fibroblasts and stimulates their transdifferentiation into activated myofibroblasts that proliferate, migrate, and secrete collagen and other matrix component. Focusing on the association between gene expression and phenotype, one study showed that esophageal narrowing was associated with increased expression of CCL26, ALOX15, GRK5, CPA3, and TRIM2 in adults with EoE,6 whereas another study showed that pediatric patients with EoE with food impaction had distinct expression of regulators of esophageal motility, mast cell markers, and TH2-associated transcripts.7 Regarding endotypes, 3 clusters associate with distinct endotypes (ie, EoE endotypes 1-3) despite similar eosinophil levels.4 Interestingly, EoE endotype 3 was associated with the narrow-caliber esophagus and enriched for epithelial genes that lose expression, particularly ACPP, CITED2, CTNNAL1, EML1, FLG, GRPEL2, MT1M, PNLIPPR3, and TSPAN12. [...]up to 50% of patients might not even undergo evaluation because biopsy specimens are not deep enough to contain sufficient amount of lamina propria. [...]there is a need for better biomarkers for the fibrostenotic component of this disease.</description><subject>Autoimmune diseases</subject><subject>Biomarkers</subject><subject>Biopsy</subject><subject>Calpain</subject><subject>Chemokines</subject><subject>Chromosome 2</subject><subject>Collagen</subject><subject>Cytokines</subject><subject>Desmoglein 1</subject><subject>Endoscopy</subject><subject>Eosinophilic Esophagitis</subject><subject>Eotaxin</subject><subject>epithelial cells</subject><subject>Epithelium</subject><subject>Esophageal diseases</subject><subject>Esophagitis</subject><subject>Esophagus</subject><subject>Fibroblasts</subject><subject>fibrosis</subject><subject>Gene expression</subject><subject>Genotype &amp; phenotype</subject><subject>Helper cells</subject><subject>Humans</subject><subject>Immunoregulation</subject><subject>Inflammation</subject><subject>Interleukin 13</subject><subject>Interleukin 5</subject><subject>Lamina propria</subject><subject>Leukocytes (basophilic)</subject><subject>Leukocytes (eosinophilic)</subject><subject>Liquid oxygen</subject><subject>Lymphocytes</subject><subject>Lymphocytes T</subject><subject>Lysyl oxidase</subject><subject>Phenotypes</subject><subject>Protease</subject><subject>Protein-Lysine 6-Oxidase</subject><subject>Proteinase inhibitors</subject><subject>Smooth muscle</subject><subject>Susceptibility</subject><subject>TGF-β</subject><subject>Thymus</subject><subject>TNF-α</subject><subject>Tumor Necrosis Factor-alpha</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kE1Lw0AQhhdRbK3-AQ8S8OIldb-yyYIXLX5BoZcevC3bzWy7IU3ibqL4793S6sGDMDAz8MzL8CB0SfCUYCJuq2mljZtSTOQUs1j8CI0JlnkqCpodozHGkqQi53KEzkKocNxZIU_RiBGcEVLwMSoe9BrqkOimTOaLt8Q1Sad7B00fkk_XbxJog2vabuNqZxIIcdJr17twjk6srgNcHPoELZ8el7OXdL54fp3dz1PDadGnEoBLUlBGQEhGxarMOJaa57nIKcOcldRmxgqmhdVWEiA2k8zmhjNLMbAJutnHdr59HyD0auuCgbrWDbRDUJRSSZkoSB7R6z9o1Q6-ic9FKsOZ4AVhkaJ7yvg2BA9Wdd5ttf9SBKudVlWpnVa106owi8Xj0dUhelhtofw9-fEYgbs9EF3ChwOvgokSDZTOg-lV2br_8r8B8JmGKQ</recordid><startdate>201907</startdate><enddate>201907</enddate><creator>Ben Baruch-Morgenstern, Netali</creator><creator>Shoda, Tetsuo</creator><creator>Rothenberg, Marc E.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SS</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>201907</creationdate><title>Bagels and LOX in patients with eosinophilic esophagitis</title><author>Ben Baruch-Morgenstern, Netali ; Shoda, Tetsuo ; Rothenberg, Marc E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c428t-9ee4918231e69326bd5409a4776723043d2f5cf63a6faf91e1f593f7c43f20e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Autoimmune diseases</topic><topic>Biomarkers</topic><topic>Biopsy</topic><topic>Calpain</topic><topic>Chemokines</topic><topic>Chromosome 2</topic><topic>Collagen</topic><topic>Cytokines</topic><topic>Desmoglein 1</topic><topic>Endoscopy</topic><topic>Eosinophilic Esophagitis</topic><topic>Eotaxin</topic><topic>epithelial cells</topic><topic>Epithelium</topic><topic>Esophageal diseases</topic><topic>Esophagitis</topic><topic>Esophagus</topic><topic>Fibroblasts</topic><topic>fibrosis</topic><topic>Gene expression</topic><topic>Genotype &amp; phenotype</topic><topic>Helper cells</topic><topic>Humans</topic><topic>Immunoregulation</topic><topic>Inflammation</topic><topic>Interleukin 13</topic><topic>Interleukin 5</topic><topic>Lamina propria</topic><topic>Leukocytes (basophilic)</topic><topic>Leukocytes (eosinophilic)</topic><topic>Liquid oxygen</topic><topic>Lymphocytes</topic><topic>Lymphocytes T</topic><topic>Lysyl oxidase</topic><topic>Phenotypes</topic><topic>Protease</topic><topic>Protein-Lysine 6-Oxidase</topic><topic>Proteinase inhibitors</topic><topic>Smooth muscle</topic><topic>Susceptibility</topic><topic>TGF-β</topic><topic>Thymus</topic><topic>TNF-α</topic><topic>Tumor Necrosis Factor-alpha</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ben Baruch-Morgenstern, Netali</creatorcontrib><creatorcontrib>Shoda, Tetsuo</creatorcontrib><creatorcontrib>Rothenberg, Marc E.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ben Baruch-Morgenstern, Netali</au><au>Shoda, Tetsuo</au><au>Rothenberg, Marc E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bagels and LOX in patients with eosinophilic esophagitis</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><addtitle>J Allergy Clin Immunol</addtitle><date>2019-07</date><risdate>2019</risdate><volume>144</volume><issue>1</issue><spage>41</spage><epage>43</epage><pages>41-43</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><abstract>[...]after impaired barrier function mediated by a number of pathways, including lost expression of the homeostatic antiprotease serine protease inhibitor, Kazal type 7,4 the epithelium releases the pro-TH2 cytokine thymic stromal lymphopoietin, which is encoded for by the chief EoE susceptibility locus on 5q22, as well as other proinflammatory cytokines, including the alarmin IL-33.1 This initiates the TH2 inflammatory cascade by promoting secretion of TH2 cell–derived inflammatory cytokines, including IL-5 and IL-13.1 IL-13 stimulates the esophageal epithelium to secrete chemokines, such as CCL26 (eotaxin-3), and disrupts the epithelial barrier by downregulating expression of the adhesion molecule desmoglein 1 and simultaneously upregulating the protease calpain 14, which is the gene product encoded for by another chief EoE susceptibility loci (2p23).1,5 These processes promote accumulation of immune cells, predominantly eosinophils, mast cells, and basophils, that secrete TGF-β, a main cytokine in the fibrotic network.1 TGF-β is also generated by regulatory T cells that are overrepresented in the esophagi of patients with EoE.1 TGF-β acts on fibroblasts and stimulates their transdifferentiation into activated myofibroblasts that proliferate, migrate, and secrete collagen and other matrix component. Focusing on the association between gene expression and phenotype, one study showed that esophageal narrowing was associated with increased expression of CCL26, ALOX15, GRK5, CPA3, and TRIM2 in adults with EoE,6 whereas another study showed that pediatric patients with EoE with food impaction had distinct expression of regulators of esophageal motility, mast cell markers, and TH2-associated transcripts.7 Regarding endotypes, 3 clusters associate with distinct endotypes (ie, EoE endotypes 1-3) despite similar eosinophil levels.4 Interestingly, EoE endotype 3 was associated with the narrow-caliber esophagus and enriched for epithelial genes that lose expression, particularly ACPP, CITED2, CTNNAL1, EML1, FLG, GRPEL2, MT1M, PNLIPPR3, and TSPAN12. [...]up to 50% of patients might not even undergo evaluation because biopsy specimens are not deep enough to contain sufficient amount of lamina propria. [...]there is a need for better biomarkers for the fibrostenotic component of this disease.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>31051184</pmid><doi>10.1016/j.jaci.2019.03.034</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0091-6749
ispartof Journal of allergy and clinical immunology, 2019-07, Vol.144 (1), p.41-43
issn 0091-6749
1097-6825
language eng
recordid cdi_proquest_miscellaneous_2229236817
source Elsevier
subjects Autoimmune diseases
Biomarkers
Biopsy
Calpain
Chemokines
Chromosome 2
Collagen
Cytokines
Desmoglein 1
Endoscopy
Eosinophilic Esophagitis
Eotaxin
epithelial cells
Epithelium
Esophageal diseases
Esophagitis
Esophagus
Fibroblasts
fibrosis
Gene expression
Genotype & phenotype
Helper cells
Humans
Immunoregulation
Inflammation
Interleukin 13
Interleukin 5
Lamina propria
Leukocytes (basophilic)
Leukocytes (eosinophilic)
Liquid oxygen
Lymphocytes
Lymphocytes T
Lysyl oxidase
Phenotypes
Protease
Protein-Lysine 6-Oxidase
Proteinase inhibitors
Smooth muscle
Susceptibility
TGF-β
Thymus
TNF-α
Tumor Necrosis Factor-alpha
title Bagels and LOX in patients with eosinophilic esophagitis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T20%3A49%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bagels%20and%20LOX%20in%20patients%20with%20eosinophilic%20esophagitis&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Ben%20Baruch-Morgenstern,%20Netali&rft.date=2019-07&rft.volume=144&rft.issue=1&rft.spage=41&rft.epage=43&rft.pages=41-43&rft.issn=0091-6749&rft.eissn=1097-6825&rft_id=info:doi/10.1016/j.jaci.2019.03.034&rft_dat=%3Cproquest_cross%3E2229236817%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c428t-9ee4918231e69326bd5409a4776723043d2f5cf63a6faf91e1f593f7c43f20e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2250564813&rft_id=info:pmid/31051184&rfr_iscdi=true